Alzheimer’s setback as promising drug shows no benefit in clinical trials – The Guardian

January 9, 2018 by  
Filed under Alzheimers News

Sponsored By

The Guardian
Alzheimer's setback as promising drug shows no benefit in clinical trials
The Guardian
The quest to develop drugs to treat Alzheimer's disease has experienced a new setback, with a promising medication failing to show benefits in the latest series of clinical trials. Earlier trials had suggested that the drug idalopirdine, from the
Medication did not decrease cognitive loss in patients with Alzheimer's diseaseEurekAlert (press release)

all 2 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*